Skip to main content ( press enter )

Search

Reset filter
Displaying results 654 - 660 of 1159
Cancer Cachexia Clinical and Research Integration Program (CaXI)
Cancer cachexia is a cancer-induced wasting syndrome which affects 30% of all cancer patients and 80% of patients with advanced cancers.It is different from malnutrition as it cannot be reversed by increasing calorie intake. As... Read more
Recurrent non-invasive breast tumours may not always be related to the primary tumour
Recurrent non-invasive breast tumours may not always be related to the primary tumour
Patients with recurrent tumours genetically distinct from the primary tumour may require different treatment. More than 10 per cent of cases of recurrent ductal carcinoma in situ (DCIS) of the breast... Read more
Faces of Discovery: Kylie Gorringe
Kylie Gorringe is a Associate Professor and Group Leader at Peter Mac. We find out why she chose her path, what inspires her every day, and the goals that keep her going in the lab, the clinic, and beyond. What are... Read more
LuPSMA shows promise as first-line treatment for prostate cancer
A targeted radioactive infusion that is a game-changer in late-stage prostate cancer can also dramatically improve outcomes for patients in earlier stages of this disease, a Peter Mac-led study has shown. Lutetium-177 PSMA-617... Read more
Ensuring First Nations patients feel culturally safe
Peter Mac is working to improve the cultural safety of First Nations people receiving cancer care, via two new Australian Government and Cancer Australia-funded projects. These projects will foster new connections between... Read more
Peter Mac nurses leading the way in sepsis care
New research from Peter Mac highlights just how critical the role of nurses is in recognising and managing sepsis, a condition associated with one in five deaths worldwide. The study, published today in BMJ Open Quality was led... Read more
Back to top